A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC).


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
01 2020
Historique:
received: 16 04 2019
revised: 21 08 2019
accepted: 22 08 2019
pubmed: 29 8 2019
medline: 20 5 2021
entrez: 29 8 2019
Statut: ppublish

Résumé

Inherited retinal diseases (IRDs) cause visual loss due to dysfunction or progressive degeneration of photoreceptors. These diseases show marked phenotypic and genetic heterogeneity. The Israeli IRD consortium (IIRDC) was established in 2013 with the goal of performing clinical and genetic mapping of the majority of Israeli IRD patients. To date, we recruited 2,420 families including 3,413 individuals with IRDs. On the basis of our estimation, these patients represent approximately 40% of Israeli IRD patients. To the best of our knowledge, this is, by far, the largest reported IRD cohort, and one of the first studies addressing the genetic analysis of IRD patients on a nationwide scale. The most common inheritance pattern in our cohort is autosomal recessive (60% of families). The most common retinal phenotype is retinitis pigmentosa (43%), followed by Stargardt disease and cone/cone-rod dystrophy. We identified the cause of disease in 56% of the families. Overall, 605 distinct mutations were identified, of which 12% represent prevalent founder mutations. The most frequently mutated genes were ABCA4, USH2A, FAM161A, CNGA3, and EYS. The results of this study have important implications for molecular diagnosis, genetic screening, and counseling, as well as for the development of new therapeutic strategies for retinal diseases.

Identifiants

pubmed: 31456290
doi: 10.1002/humu.23903
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-149

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Dror Sharon (D)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Tamar Ben-Yosef (T)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Nitza Goldenberg-Cohen (N)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Ophthalmology, Bnai Zion Medical Center, Haifa, Israel.
The Krieger Eye Research Laboratory, Felsenstein Medical Research Center (FMRC), Petach Tikva, Israel.

Eran Pras (E)

Department of Ophthalmology, Assaf-Harofeh Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Libe Gradstein (L)

Department of Ophthalmology, Soroka Medical Center and Clalit Health Services, Faculty of Health Sciences, Ben-Gurion University, Beer Sheva, Israel.

Shiri Soudry (S)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Ophthalmology, Rambam Healthcare Campus, Haifa, Israel.

Eedy Mezer (E)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Department of Ophthalmology, Rambam Healthcare Campus, Haifa, Israel.

Dinah Zur (D)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ophthalmology Division, Tel Aviv Medical Center, Tel Aviv, Israel.

Anan H Abbasi (AH)

Ziv Medical Center, Safed, Israel.
The Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.

Christina Zeitz (C)

INSERM, CNRS, Institut de la Vision, Sorbonne Université, Paris, France.

Frans P M Cremers (FPM)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Muhammad I Khan (MI)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Jaime Levy (J)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Ygal Rotenstreich (Y)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer, Israel.

Ohad S Birk (OS)

The Morris Kahn Laboratory of Human Genetics at the National Institute of Biotechnology in the Negev, Ben-Gurion University, Beer Sheva, Israel.
Genetics Institute, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University, Beer Sheva, Israel.

Miriam Ehrenberg (M)

Ophthalmology Unit, Schneider Children's Medical Center in Israel, Petach Tikva, Israel.

Rina Leibu (R)

Department of Ophthalmology, Rambam Healthcare Campus, Haifa, Israel.

Hadas Newman (H)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ophthalmology Division, Tel Aviv Medical Center, Tel Aviv, Israel.

Noam Shomron (N)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eyal Banin (E)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Ido Perlman (I)

Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Ophthalmology Division, Tel Aviv Medical Center, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH